InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-34.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Lo Andrew, Director. Insider active across 3 companies, notably AbCellera Biologics Inc.. In total, 7 disclosures have been published. Breakdown: 2 buys · 2 sells. Total volume traded: €6.7m. Activity tracked since 3 December 2021. The latest transaction was filed on 17 November 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
3,990 sharesCommon StockSEC:0001470831-26-000634:0
36,801 shares@ US$66.626337.8% of flowCommon StockSEC:0001470831-25-000357:0
6,589 shares0Common StockSEC:0000950170-25-089674:0
100,000 shares@ US$38.49996.1% of flowCommon StockSEC:0000950170-25-064558:0
52,142 shares0Common SharesSEC:0001140361-22-033876:0
6,000 shares@ US$12.900.0005% mcap50.0% of flowCommon StockSEC:0000899243-22-000188:0
Canonical exit: 29 Mar 2022 (T+90)
86,938 shares@ US$14.020.086% mcap50.0% of flowShare Option (right to buy)SEC:0001209191-21-068291:0
Canonical exit: 3 Mar 2022 (T+90)
7 of 7 declarations
About Lo Andrew
Andrew Lo is a Board Member at AbCellera Biologics Inc. and BridgeBio Pharma, Inc. In this role, he participates in the governance of these companies, bringing his expertise in biotechnology and life sciences.
